Sol-Gel Technologies (SLGL) Research & Development (2017 - 2026)

Sol-Gel Technologies' (SLGL) quarterly Research & Development came in at $2.8 million in Q1 2026, down 68.49% year-on-year from $8.8 million in Q1 2025, and down 22.27% on a QoQ basis from $3.6 million in Q4 2025.

Sol-Gel Technologies (SLGL) Research & Development (2017 - 2026) Analysis & Trends

Sol-Gel Technologies (SLGL) has 10 years of Research & Development data on file, last reported at $2.8 million in Q1 2026.

  • On a quarterly basis, Research & Development fell 68.49% year-over-year to $2.8 million in Q1 2026; TTM through Mar 2026 was $16.7 million, a 21.38% decrease from a year earlier, with the FY2025 full-year figure at $22.8 million, up 28.09% from the prior year.
  • Research & Development for Q1 2026 stood at $2.8 million, down from $3.6 million in the prior quarter.
  • Over the last five years, Research & Development for SLGL reached as high as $9.4 million in Q1 2023 and fell as low as $2.0 million in Q3 2022.
  • Historically, Research & Development has averaged $4.7 million across 5 years, with a median of $4.6 million in 2025.
  • Across the five-year window, Research & Development soared 132.21% in 2023 and slumped 68.49% in 2026, its largest moves.
  • Year by year, Research & Development stood at $4.2 million in 2022, then fell by 1.09% to $4.2 million in 2023, then grew by 24.6% to $5.2 million in 2024, then sank by 31.04% to $3.6 million in 2025, then dropped by 22.27% to $2.8 million in 2026.
  • Per Business Quant data, the three most recent Research & Development figures were $2.8 million in Q1 2026, $3.6 million in Q4 2025, and $5.7 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -17.94 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 1.46 Mn
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 541.22 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 961.60 Mn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 1.54 Bn
7 Belite Bio 61.40 Bn 61.40 Bn - 15.66 Mn
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -443.00 Mn
9 Revolution Medicines 37.37 Bn 37.37 Bn - 343.97 Mn
10 Sol-Gel Technologies 234.04 Mn 223.91 Mn - 2.79 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.79 Mn
Dec 31, 2025 3.58 Mn
Sep 30, 2025 5.73 Mn
Jun 30, 2025 4.65 Mn
Mar 31, 2025 8.84 Mn
Dec 31, 2024 5.20 Mn
Sep 30, 2024 4.82 Mn
Jun 30, 2024 2.44 Mn
Mar 31, 2024 5.35 Mn
Dec 31, 2023 4.17 Mn
Sep 30, 2023 4.67 Mn
Jun 30, 2023 5.31 Mn
Mar 31, 2023 9.39 Mn
Dec 31, 2022 4.22 Mn
Sep 30, 2022 2.04 Mn
Jun 30, 2022 2.38 Mn
Mar 31, 2022 4.04 Mn
Dec 31, 2021 4.99 Mn
Sep 30, 2021 5.99 Mn
Jun 30, 2021 6.93 Mn